Skip to main content
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):e150–e157. doi: 10.1097/QAI.0b013e3182948d82

Table 2.

Observed and excess mortality rates, and standardized mortality ratios, among 64,836 HIV-infected patients initiating combination antiretroviral therapy in the China National Free Antiretroviral Treatment Program from 2003 – 2009

Mortality 2003–2004 2005–2007 2008–2009 Total
Observed death 733 3,815 4,029 8,577
Expected death 23.8 166.4 236.6 426.8
Person year at follow up 7,754 55,336 72,419 135,509
Observed mortality rate (95% CI) (per 100 person-years) 9.5 (8.8 – 10.2) 6.9 (6.7 – 7.1) 5.6 (5.4 – 5.8) 6.3 (6.2 – 6.4)
Excess mortality rate (95% CI) (per 100 person-years) 9.1 (8.5 – 9.8) 6.6 (6.4 – 6.8) 5.2 (5.0 – 5.4) 6.0 (5.9 – 6.1)
Standardized mortality ratio (95% CI)* 30.8 (28.6 – 33.1) 22.9 (22.2 – 23.7) 17.0 (16.5 – 17.6) 20.1 (19.7 – 20.5)

Calculated as 100× (observed death/person years at follow up)

Calculated as 100× [(observed death-expected death)/person years at follow up)]

*

Calculated as 100× (observed death/expected death)